Clinical Trial Update: A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study evaluating targeted agents for patients with recurrent or persistent endometrial cancer, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Endometrial Cancer | Phase 1, Phase 2 | Status: RECRUITING